Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Combining brain stimulation and therapy for headaches after mild brain injuries

Official title: Combined Nonpharmacological Therapies for MTBI-Related Headaches

Run by Veterans Medical Research Foundation · NCT05176392 · Data updated 2026-11-12

This study is testing if combining brain stimulation with therapy can help veterans and active military personnel manage headaches caused by mild brain injuries.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment240 (estimated)
SponsorVeterans Medical Research Foundation
Academic / other
Locations1 site (San Diego, California)
StatusRecruiting
StartedJanuary 1, 2022
Main results expectedAugust 31, 2025
Study endsAugust 31, 2025
Registry record updatedNovember 21, 2024
Trial IDNCT05176392 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are veterans or active military individuals aged 18-65 with chronic headaches following a mild traumatic brain injury.

Probably not a fit

Patients with a history of major psychiatric disorders, chronic headache conditions prior to mTBI, or those who are pregnant will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of repetitive transcranial magnetic stimulation (rTMS) combined with telehealth therapy in managing headaches related to mild traumatic brain injury (mTBI). A total of 240 veterans or active military personnel will be enrolled and randomized into four groups to receive either active or sham rTMS along with headache management or education. Participants will undergo a series of in-person visits and telehealth sessions over a period of 6-7 months, including assessments to evaluate headache symptoms and neurobehavioral outcomes. The goal is to determine if the combined approach leads to a significant reduction in headache severity compared to placebo treatments.

Why it matters

Potential benefit: If successful, this approach could significantly alleviate headache symptoms in patients suffering from mTBI.

How similar studies have gone: Other studies have shown promise with rTMS for headache management, but this specific combination approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Mild Traumatic Brain Injury (mTBI)
2. Chronic headaches \> 3 months after injury
3. Aged 18-65
4. No prior TMS treatment
5. Persistent Headaches with an intensity \> 30 / 100
6. No history of daily headache prior to mTBI

Exclusion Criteria:

1. Pregnant
2. Pacemaker or any metal in body that would prevent MRI
3. History of dementia or major psychiatric disease, such as bipolar disorder or schizophrenia
4. Presence of any other chronic neuropathic pain states
5. History of seizure
6. Pending litigation
7. Can't understand English
8. History of chronic headache like migraine prior to mTBI
9. Evidence in chart of exacerbation of depressive/anxiety symptoms, active substance dependence, suicidal intent or attempt within previous month

Where it's running

  • VA San Diego Healthcare System
    San Diego, California, United States
    Recruiting

Study contacts

  • Principal investigator: Albert Y Leung, MD — San Diego Veterans Healthcare System
  • Study coordinator: Caleb Lopez, BS
  • Email: caleb.lopez@va.gov
  • Phone: 858-552-8585

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.